Related Experiment Video

Updated: May 26, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Histone acetyltransferases and deacetylases: molecular and clinical implications to gastrointestinal carcinogenesis

Wei-Jian Sun1, Xiang Zhou, Ji-Hang Zheng

  • 1The 2nd Affiliated Hospital, Wenzhou Medical College, China.

Acta Biochimica Et Biophysica Sinica
|December 24, 2011
PubMed

Insights

Histone acetylation, regulated by enzymes like histone acetyltransferases and deacetylases, plays a key role in gastrointestinal (GI) carcinogenesis. Histone deacetylase inhibitors show promise as novel cancer therapeutics.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Gastrointestinal (GI) carcinogenesis is a significant global health concern.
  • Epigenetic alterations, particularly aberrant histone acetylation, are increasingly recognized in cancer development.
  • Histone acetyltransferases (HATs) and histone deacetylases (HDACs) dynamically regulate protein acetylation.

Purpose of the Study:

  • To provide an overview of histone acetylation.
  • To identify major groups of HATs and HDACs.
  • To explore the link between these enzymes and GI carcinogenesis.

Main Methods:

  • Literature review of histone acetylation.
  • Overview of HAT and HDAC enzyme families.
  • Analysis of recent studies on enzyme roles in GI cancer.

Main Results:

  • Histone acetylation is a critical epigenetic mechanism in GI tumorigenesis.
  • Specific HATs and HDACs are implicated in the progression of GI cancers.
  • Histone deacetylase inhibitors (HDACis) are emerging as potential therapeutic agents.

Conclusions:

  • Aberrant histone acetylation is pivotal in GI carcinogenesis.
  • Targeting HATs and HDACs offers a promising therapeutic strategy for GI cancers.
  • HDAC inhibitors represent a novel class of drugs for cancer treatment.

More Related Videos

An Acetyl-Click Chemistry Assay to Measure Histone Acetyltransferase 1 Acetylation05:44

An Acetyl-Click Chemistry Assay to Measure Histone Acetyltransferase 1 Acetylation

Published on: January 26, 2024

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue09:43

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue

Published on: November 30, 2018

Related Concept Videos

Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...